Clinical Trial Update: Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating a dendritic cell immunotherapy approach for colorectal cancer that has metastasized to the liver.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Dendritic Cell-Immunotherapy

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Colorectal Carcinoma, Hepatic Metastasis | Phase 2 | Status: UNKNOWN